/_media/adv/web/images/2011/20111124_Arthrex_TB-378x82.jpg

Subscriptions

Advertising

Resources

About Us

Contact Us

Create An Account Forgot Your Password?
Trouble logging in or creating an account? click here
Home This Month E-Weekly Newsletter Building a Facility Article Archive Second Opinions
Search:
Benchmarking
General Surgery
Accrediting/Quality
Anesthesia
Code/Bill/Reimburse
Building/Renovating
/_media/adv/web/images/2011/20110502_Provista_LB-154x100.gif
/_media/adv/web/images/2012/20120201_Provation_LB-154x100.gif
/_media/adv/web/images/2011/20111226_Soma_LB-154x100.gif
/_media/adv/web/images/2012/20120126_ASP_LB-154x100.gif
Outpatient Surgery E-Weekly

Contact Congress Over Drug Shortage Issues

A Kentucky congressman is urging surgical facilities to contact their members of Congress and request that they sign his letter demanding changes to...

N.J. Posts ASC Inspection Reports Online

State and federal inspection reports of New Jersey's ASCs are now available online, giving patients an opportunity to make more informed choices abo...

Are Opioids Necessary?

While it's not always practical, or even possible, to eliminate opioids from your post-op pain management regiment, reducing their use in favor of n...

Archive >  Ambulatory Anesthesia 2006

Prophylaxis and Treatment of PONV

A review of your antiemetic therapy options for PONV prophylaxis.

Tong J. Gan, MD

Nearly a third of my patients suffer from post-operative nausea and vomiting, despite the introduction of new antiemetic agents and significant advances in the area of PONV. This is a confounding problem, as most episodes of PONV occur after discharge, even up to 48 hours after surgery. Many of these patients didn't have symptoms while in the surgical unit. So what are we to do?

Sign in to continue reading.
Email Address:
Password:
Categories: Anesthesia, Business Management, Patient Management
Keywords:
P/neurokinin-1 (NK1) receptor antagonists; Serotonin receptor antagonists ' equally safe; Older generation antiemetics; Preventive care ' what you can do; What about cost-effectiveness?; Ambulatory; Anzemet; Avoiding; Avoiding PONV; Baseline PONV Risk Use; December; Dolasetron; Droperidol; Emend; Europe; FDA; FDA's July; FDA-approved; Female; Gan, MD; High-dose; Hill; IV; IV. So; J. Gan, MD; July; Kytril; MD; Members; Merck's Emend; NSAIDs; Ondansetron; P/neurokinin; PONV; PONV Risk Use; PONV). Navoban; Patients; Pericardium; Preventive; Procedures; Promethazine; Reduce Baseline PONV Risk Use;... show all keywords
P/neurokinin-1 (NK1) receptor antagonists; Serotonin receptor antagonists ' equally safe; Older generation antiemetics; Preventive care ' what you can do; What about cost-effectiveness?; Ambulatory; Anzemet; Avoiding; Avoiding PONV; Baseline PONV Risk Use; December; Dolasetron; Droperidol; Emend; Europe; FDA; FDA's July; FDA-approved; Female; Gan, MD; High-dose; Hill; IV; IV. So; J. Gan, MD; July; Kytril; MD; Members; Merck's Emend; NSAIDs; Ondansetron; P/neurokinin; PONV; PONV Risk Use; PONV). Navoban; Patients; Pericardium; Preventive; Procedures; Promethazine; Reduce Baseline PONV Risk Use; Risk Use; States; Tong J. Gan, MD; Transdermal; United States; Zofran; abdominal; achieve; act; action; activity; acupoint; acupressure; additional; administer; administered; administration; adults; advances; adverse; advocate; afferents; age-related; agent; agonist; alternate; ambulatory; analgesia; anesthesia; anesthetics; antagonist; anti-inflammatory; anti-nausea; anti-vomiting; antiemetic; antiemetics; appears; applied; approach; approval; area; at-home; avoiding; based; baseline; belongs; binding; black; blocking; box; broader; called; cardiac; care; chemoreceptor; chemotherapy-induced; chemotherapy-related; choices; cholinergic; cleared; combination; combined; compared; concentration; confounding; consequence; contraindications; control; corticosteroid; cost; cost-effective; cost-effectiveness; costs; current; decrease; degree; delay; demonstrated; determinant; determined; dexamethasone; difference; discharge; disintegrating; distinguish; dolasetron; dopamine; dopaminergic; dose; droperidol; drug; drugs; dry; duration; dystonic; early; effect; effective; effectively; effects; efficacious; efficacy; efforts; electrical; emesis; end; ephedrine; episode; equally; established; estimated; etiology; evaluating; evening; evidence; exert; expensive; experience; factors; favorable; first-line; found; four-hour; gastrointestinal; general; generation; generic; give; good; granisetron; group; gynecologic; half; haloperidol; high; high-risk; higher; highly; histaminergic; history; hospital; hours; immediately; important; incidence; include; increase; induction; inhaled; inpatient; intraoperative; intravenously; introduction; involved; issued; lack; laparoscopic; limitations; limited; literature; long; low; lower; maintenance; major; make; management; marketed; medical; medications; member; metoclopramide; mg; mild; mind; minimizing; minutes; modalities; motion; mounting; mouth; multi-center; nausea; nerve; news; nitrous; nonsmoking; nonsteroidal; not-so-good; notably; occur; older; ondansetron; onset; open; opioid; optimal; option; oral; orally; order; outpatient; oxide; oxygen; pain; patient; percent; phenothiazine; physicians; placebo; poorly; post-discharge; post-op; post-operative; postoperative; predictive; presence; prevent; preventing; prevention; procedures; prochlorperazine; profile; prolonged; prophylactic; prophylaxis; propofol; protective; provided; published; randomized; rate; receive; receiving; recent; receptor; recommended; recovery; reduce; reduces; regional; related; remains; represents; rescue; response; resulting; reviewed; risk; role; room; rundown; satisfaction; satisfactory; scopolamine; sedation; select; selective; serotonergic; serotonin; setting; short; showed; showing; shown; sickness; side; side-effect; signals; significant; significantly; similar; similarly; single; specific; spectrum; spend; status; stimulation; strabismus; structurally; studied; studies; study; subsequent; substance; successfully; suffer; suggest; suggested; suggests; suitable; surgery; surgical; symptoms; systems; taking; target; tested; therapies; therapy; throat; time; timing; tonsillectomies; transcutaneous; transdermal; treat; treating; treatment; trial; trigger; tropisetron; type; unclear; undergoing; underrecognition; undesirable; undoubtedly; universal; vagal; volatile; vomiting; warning; ways; widely; works; zone

© Copyright Herrin Publishing Partners LP 2011. REPRODUCTION OF THIS COPYRIGHTED CONTENT IS STRICTLY PROHIBITED. We encourage LINKING to this content; view our linking policy here.

PRODUCT & SERVICE RESOURCES
Did You See This?
A showcase of products and services geared to make your facility better.

Architects' Showcase
Is a beautiful, efficient new facility in your future?
/_media/adv/web/images/2011/20111111_CareFusion_AR-300x250.jpg
Other Articles That May Interest You
Nitrous Oxide Associated With Long-Term Risk of Heart Attack
Follow-up study shows risk is nearly 60% higher for patients receiving general anesthesia with nitrous oxide.
AmSurg to Buy National Surgical Care
Outpatient surgery development and management firm plans expansion.
Did Docs Perform Unnecessary Spinal Surgery?
North Carolina Medical Board says plasma disc decompression on 7 patients wasn't justified.